SCHEMBL25565735

SCHEMBL25565735

CC(C)Oc1cc(OC(C)C)cc(-c2cc(OC(C)C)cc(OC(C)C)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.42
PDE4D Q08499 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
ALDH1A1 P00352 1/20 0.40
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
ALDH1A3 P47895 1/20 0.39
KMT2A Q03164 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
CYP1A1 P04798 3/20 0.37
CYP1B1 Q16678 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2E1 P05181 2/20 0.37
CYP3A4 P08684 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8370932 0.91 ALDH1A1 (0.44) PDE4APDE4DRXRARXRBALDH1A1
SCHEMBL23458208 0.80 ALDH1A1 (0.61) PDE4APDE4DALDH1A1GRIN2DGRIN3B
SCHEMBL8284844 0.80 FFAR4 (0.42) PDE4APDE4DALDH1A1GRIN2DGRIN3B
SCHEMBL18800170 0.80 ALDH1A1 (0.61) PDE4APDE4DALDH1A1GRIN2DGRIN3B
SCHEMBL2154535 0.78 GRIN2D (0.41) PDE4APDE4DALDH1A1GRIN2DGRIN3B
SCHEMBL21202092 0.78 ALDH1A1 (0.38) PDE4APDE4DRXRARXRBALDH1A1
SCHEMBL387559 0.78 ALDH1A1 (0.38) PDE4APDE4DRXRARXRBALDH1A1
SCHEMBL389494 0.78 ALDH1A1 (0.38) PDE4APDE4DRXRARXRBALDH1A1
SCHEMBL25084178 0.78 ALDH1A1 (0.38) PDE4APDE4DRXRARXRBALDH1A1
SCHEMBL5233624 0.78 ALDH1A1 (0.42) RXRARXRBALDH1A1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY POLN, TLR9, TSG101 PDE4A 1956/4885PDE4D 3559/4885RXRA 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.